Postbiotic Ingredient Market
Dublin, Aug. 31, 2026 (GLOBE NEWSWIRE) — The “Postbiotic Ingredient Market Report 2026” has been added to ResearchAndMarkets.com’s offering.
The global postbiotic ingredient market is experiencing rapid expansion, driven by rising awareness of gut health, increased adoption of microbiome-focused products and sustained growth across the functional food and dietary supplement industries. The market is projected to grow from $1.2 billion in 2025 to $1.33 billion in 2026, representing a compound annual growth rate (CAGR) of 10.9%.
Historic growth in the postbiotic ingredient market has been supported by greater consumer understanding of gut health benefits, wider use of probiotic products, expanding functional food consumption and continued development of the dietary supplement sector. Early research into the relationship between the microbiome and overall health has also encouraged manufacturers to invest in postbiotic ingredients for food, beverage, supplement and wellness applications.
Looking ahead, the global postbiotic ingredient market is forecast to reach $2.02 billion by 2030, advancing at a CAGR of 11.1%. Growth during the forecast period is expected to be fueled by increasing demand for immune health products, the rising prevalence of lifestyle-related disorders and a stronger focus on preventive healthcare nutrition. Expanding personalized nutrition solutions and greater investment in microbiome-based research and development are also expected to create new opportunities for postbiotic ingredient manufacturers.
Key postbiotic ingredient market trends include the increasing adoption of clean-label and naturally derived formulations in functional foods. Manufacturers are also integrating postbiotics into personalized nutrition and gut health solutions while expanding the use of fermentation-derived bioactive compounds in dietary supplements. In pharmaceutical and nutrition applications, microbiome-targeted product development is gaining momentum as businesses seek stable, non-living alternatives that can withstand varied processing and storage conditions.
Rising demand for preventive healthcare is expected to remain a major market growth driver. Greater awareness of early intervention, healthy lifestyles and long-term disease prevention is encouraging consumers to seek nutritional products that support immune, digestive and metabolic health. Postbiotic ingredients can help support microbiome balance and related wellness functions, increasing their relevance within preventive nutrition strategies. According to the Organisation for Economic Co-operation and Development’s Health at a Glance 2025 report, preventive care represented approximately 3% of total health expenditure across OECD countries, highlighting significant potential for further investment in prevention-focused health solutions.
Product innovation is increasingly centered on clean-label postbiotic formulations that offer processing stability and compatibility across supplements, foods and beverages. In February 2024, Ireland-based taste and nutrition company Kerry Group PLC launched Plenibiotic, a rice-derived postbiotic ingredient developed to support gut and skin health. The ingredient maintains stability across varying temperature, moisture and pH conditions and can be used at a low serving size, supporting formulation flexibility in both human nutrition and pet health applications.
Strategic acquisitions are also influencing the competitive development of the postbiotic ingredient market. In June 2023, France-based microbiota care company Biocodex acquired TargEDys for an undisclosed amount. The acquisition was intended to strengthen Biocodex’s microbiome portfolio, accelerate TargEDys’ development and support Biocodex’s strategic objective of expanding its position in microbiota care through microbiome-based innovation. TargEDys develops microbiome-based nutraceutical solutions, including precision probiotic and postbiotic products targeting appetite control, weight management, undernutrition and mental health support.
North America dominated the postbiotic ingredient market in 2025, supported by established dietary supplement consumption, strong consumer interest in digestive health and continued investment in microbiome research. Asia-Pacific is expected to be the fastest-growing region during the forecast period. The regions covered by the market analysis include Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. Countries covered include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, the United Kingdom, the United States, Canada, Italy and Spain.
Markets Covered:
1) By Product Type: Powder; Liquid; Capsules; Tablets; Other Product Types
2) By Source: Plant-Based; Animal-Based; Microbial-Based; Other Sources
3) By Distribution Channel: Online Stores; Supermarkets or Hypermarkets; Specialty Stores; Other Distribution Channels
4) By Application: Dietary Supplements; Functional Food And Beverages; Animal Feed; Pharmaceuticals; Personal Care; Other Applications
Subsegments:
1) By Powder: Spray Dried Postbiotic Powder; Freeze Dried Postbiotic Powder; Microencapsulated Postbiotic Powder; Heat Treated Postbiotic Powder; Fermented Postbiotic Powder
2) By Liquid: Concentrated Postbiotic Liquid; Fermented Postbiotic Liquid; Stabilized Postbiotic Liquid; Ready to Use Postbiotic Liquid; Water Soluble Postbiotic Liquid
3) By Capsules: Hard Shell Postbiotic Capsules; Soft Gel Postbiotic Capsules; Delayed Release Postbiotic Capsules; Vegetarian Postbiotic Capsules; Enteric Coated Postbiotic Capsules
4) By Tablets: Chewable Postbiotic Tablets; Effervescent Postbiotic Tablets; Sustained Release Postbiotic Tablets; Film Coated Postbiotic Tablets; Orally Disintegrating Postbiotic Tablets
5) By Other Product Types: Cell Free Supernatants; Inactivated Microbial Biomass; Peptidoglycan Derivatives; Lipoteichoic Acid Extracts; Exopolysaccharide Compounds; Enzyme Derived Metabolites; Fermentation Derived Organic Acids; Bacterial Lysate Fractions; Microbial Cell Wall Fragments; Post Fermentation Bioactive Compounds
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 250 |
| Forecast Period | 2026-2030 |
| Estimated Market Value (USD) in 2026 | $1.33 Billion |
| Forecasted Market Value (USD) by 2030 | $2.02 Billion |
| Compound Annual Growth Rate | 11.1% |
| Regions Covered | Global |
The companies featured in this Postbiotic Ingredient market report include:
- Nestle S.A.
- Unilever PLC
- BASF SE
- Danone S.A.
- Archer Daniels Midland (ADM)
- Givaudan SA
- dsm-firmenich
- Associated British Foods (ABF)
- CJ CheilJedang
- International Flavors & Fragrances (IFF)
- Asahi Group Holdings
- Kerry Group
- Novonesis (NZYM.VI)
- Kirin Holdings
- Evonik Industries AG
- Croda International
- Symrise AG
- Clariant AG
- Ashland Inc.
- Morinaga Milk Industry
For more information about this report visit https://www.researchandmarkets.com/r/n80ire
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
- Postbiotic Ingredient Market
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
